Acquisition impact NGD has undergone multiple acquisitions and asset sales in recent years, including Movora acquiring NGD in 2023 and Vimian acquiring NGD assets in 2022, indicating a history of strategic consolidation and potential for ongoing partner or buyout discussions, licensing opportunities, or integration services with veterinary device ecosystems.

Limited scale Current employee count is 2-10 with revenue under one million, suggesting a small, niche operation that may benefit from scalable solutions, lower-touch pricing, and channel partnerships to expand market reach without heavy onboarding costs.

Vet market focus As a medical device company operating in the veterinary space, there are opportunities to pursue vet clinics, animal health distributors, and veterinary SaaS ecosystems, leveraging connections through Vimian and Movora networks for co-marketing or bundled device offerings.

Digital footprint Tech stack includes Google tools and web functionalities; there is potential to upsell digital marketing automation, CRM integration, and compliance solutions to improve lead capture, data governance, and customer engagement for veterinary customers.

Financial signals Revenue under $1M and engagement in asset sales suggest sensitivity to cost-conscious health-tech buyers; propose affordable, modular device upgrades, service plans, and favorable financing or leasing options to win budget-constrained veterinary practices.